Media More Coverage

Einstein in the Media

The New York Times interviews Meredith Hawkins, M.D., on the results of a clinical trial which showed that an aspirin-like drug helped patients manage their type 2 diabetes. Dr. Hawkins notes that the trial, which tested a generic anti-inflammatory drug from the aspirin family, demonstrated that inflammation is a good target for treating diabetes and has been a topic of discussion among endocrinologists for a long time. Dr. Hawkins is director of the Global Diabetes Initiative and professor of medicine. (Tuesday, March 16, 2010)

More coverage on other stories